ArticleBioMed research international2026
Resveratrol Mitigates Noise-Induced Cochlear Damage and Delays Hearing Loss in Wistar Rats.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Resveratrol Mitigates Noise-Induced Cochlear Damage and Delays Hearing Loss in Wistar Rats.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionThis study was aimed at evaluating the potential otoprotective effects of resveratrol (Changsha Huir Biological-Tech) on noise-induced hearing loss (NIHL) in a Wistar rat model.
methodsThe study employed a randomized controlled design. The noise used for stimulation was white noise, centered at a frequency of 4000 Hz (3564-4490 Hz), with an intensity of 100 dB SPL, for a period of 10 consecutive days at 8 h/day. Thirty rats were randomly assigned to three groups: a control nonexposed-to-noise group (n = 10) that received a vehicle solution of DMSO (dimethyl sulfoxide) (Sigma-Aldrich), a noise-exposed study group (n = 10) that received a vehicle solution of DMSO, and a resveratrol study group that was exposed to noise and received 10 mg/kg/day of resveratrol. All groups underwent distortion product otoacoustic emission (DPOAE) and auditory brainstem response (ABR) assessments at three time points: initial examination (D0), examination after 10 consecutive days of noise exposure (D15), and examination after 15 days of acoustic rest (D30). Histological evaluations were conducted on cochlear tissues after euthanasia. Statistical analyses were performed using Prism software to determine differences between groups and across time points.
resultsThe amplitude values, signal-to-noise ratios of DPOAE, ABR thresholds, and cochlear morphology between the experimental and control groups were significantly different from each other.
conclusionThe findings suggest that resveratrol exerts a partial otoprotective effect, possibly delaying the onset of NIHL. However, further research, particularly molecular research, is needed to better understand its therapeutic mechanism and its specific impact on auditory metabolic processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.